BOVIX MICROCLOX EDC, 600 mg Intramammary Suspension
BOVIX MICROCLOX EDC, 600 mg Intramammary Suspension
Authorised
- Cloxacillin
Product identification
Medicine name:
BOVIX MICROCLOX EDC, 600 mg Intramammary Suspension
BOVIX MICROCLOX EDC 600 MG SUSPENSION INTRAMAMMAIRE
Active substance:
- Cloxacillin
Target species:
-
Cattle (dairy cow at drying-off)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin600.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow at drying-off)
-
Meat and offalno withdrawal periodMeat and offal: zero days
-
Milk48hour- if calving occurs at least 42 days after treatment: 48 hours post calving. - if calving occurs less than 42 days after treatment: 44 days after last treatment.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Cardboard box with 12 syringes x 3.6 g of veterinary medicinal product and wipes.
- Cardboard box with 24 syringes x 3.6 g of veterinary medicinal product and wipes.
- Cardboard box with 60 syringes x 3.6 g of veterinary medicinal product and wipes.
- Cardboard box with 120 syringes x 3.6 g of veterinary medicinal product and wipes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Kernfarm B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Crida Pharm S.R.L.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/3515966 3/2024
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0416/001
Concerned member states:
-
Belgium
-
France
-
Germany
-
Italy
-
Poland
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/02/2025